Arrowstreet Capital Limited Partnership Sells 821,832 Shares of Relx Plc $RELX

Arrowstreet Capital Limited Partnership cut its stake in shares of Relx Plc (NYSE:RELX) by 55.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 655,390 shares of the technology company’s stock after selling 821,832 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Relx were worth $35,614,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. WPG Advisers LLC bought a new stake in shares of Relx during the 1st quarter worth approximately $28,000. NewSquare Capital LLC grew its stake in shares of Relx by 522.0% in the second quarter. NewSquare Capital LLC now owns 566 shares of the technology company’s stock valued at $31,000 after buying an additional 475 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in Relx by 99.3% during the second quarter. Caitong International Asset Management Co. Ltd now owns 608 shares of the technology company’s stock worth $33,000 after buying an additional 303 shares during the last quarter. Harbor Asset Planning Inc. acquired a new position in Relx during the second quarter worth $37,000. Finally, Elevation Point Wealth Partners LLC bought a new stake in Relx during the second quarter worth $38,000. 15.02% of the stock is currently owned by institutional investors.

Relx Stock Down 0.6%

Shares of NYSE RELX opened at $40.29 on Friday. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55. The stock’s fifty day moving average price is $43.52 and its two-hundred day moving average price is $48.34. Relx Plc has a one year low of $39.31 and a one year high of $56.33.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Barclays reissued an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Wall Street Zen downgraded Relx from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Kepler Capital Markets upgraded Relx from a “hold” rating to a “strong-buy” rating in a research note on Thursday, September 18th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Relx in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.